Visipaque Injection 320 mgI/mL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Visipaque Injection 320 mgI/mL, covering 2019-12-17 to 2019-12-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease [Phase 4]